Print Page  Close Window

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Price$105.87
Change (%) Stock is Up 1.78 (1.71%)
Intraday High$105.99
Intraday Low$103.15
Volume1,835,994
Data as of 04/25/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Headlines More >
TitleDate
Quest Diagnostics 50th Anniversary: Celebrating a Half Century of Life-Changing Results
To mark the milestone, Quest provides charitable grants of $50,000 each to the American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks MADISON, N.J., April 24, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalit... 
04/24/17
Data Diagnostics Wins Gold at the 30th Annual Edison Awards
Healthcare analytics technology from Quest Diagnostics and Inovalon enables patient data to be turned into actionable insights that inform quality, reimbursement and care outcomes MADISON, N.J., April 24, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) announced that Data Diagnostics®, a point-of-care health analytics technology, won a gold award in the Health and Wellness—Patient Care category at the 2017 Edison Awards, which honor the best innovations and in... 
04/24/17
Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook
- First quarter revenues of $1.90 billion, up 1.9% on a reported basis and up 3.0% on an equivalent basis versus 2016 - First quarter diluted EPS of $1.16 on a reported basis, up 63.4% from 2016; and $1.33 on an adjusted basis excluding amortization, up 17.7% from 2016. Excess tax benefit associated with stock-based compensation increased diluted earnings per share by $0.11 in the quarter. - Raises outlook for full year 2017 diluted EPS. Reported diluted EPS now expected to be between $4.7... 
04/20/17
Quest Diagnostics To Release First Quarter 2017 Financial Results On April 20
MADISON, N.J., April 7, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2017 results on Thursday, April 20, 2017, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dialing 888-300-0211 ... 
04/07/17
Upcoming EventsMore >
There are currently no events scheduled.
Contact Us:
Shawn Bevec
Executive Director Investor Relations
973-520-2900
Investor@QuestDiagnostics.com

Company Calendar
April 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-6-5-4-3-2-11
2345
04/05/17
DEF 14A
Formats:  Excel HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
678
9101112131415
161718192021
04/21/17
10-Q
Formats:  Excel HTML Adobe PDF Word XBRL
22
23242526272829
30515253545556

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.